Cambrex Wiesbaden
Our specialist team in Wiesbaden has strong expertise in enzyme screening and developed more than 800 proprietary enzymes of different classes.

About the plant
Consisting of nine employees, our specialist team in Wiesbaden has strong expertise in enzyme screening and developed more than 800 proprietary enzymes of different classes. For easy implementation of biocatalytic conversion, our customers are provided with fully optimized processes and all technical support required.
Through efficient and environmentally friendly enzymatic syntheses, we can manufacture highly pure regio-, chemo-, and enantioselective intermediates and APIs for our customers in a cost-efficient way.
Problematic chemicals, such as CN waste, can be degraded to harmless compounds.
Facility Details
- 1000 strains (yeast, bacteria, fungi, algae)
- In-house cultivation, screening, cloning, and gene discovery
- In-house lab scale enzyme production
- Multi-ton scale enzyme production with external partners
Certifications
Activity
- Peptide, protein, hormone & enzyme, BIOLOGICS manufacturing
Features
- Uses: Investigational, Commercial (Phase IV), Preclinical, Phase I, Phase II, Phase III, Human
- Toxicity (OEB classification):
- DEA: N/A
- BSL:
- Therapeutic areas: N/A
- Markets: FDA (USA), EMA (EU)
Batch Size / Reactor
- Small, Medium, Large, 1 - 10 sqm, 10 - 50 sqm, 50 - 100 sqm, 100 - 200 sqm
Services
- Development services, Analytical / QC services, Logistics, R&D, QbD (Quality by Design), Process development, Process optimization, Process validation, Lyophilization cycle development, Stability studies design, Stability studies execution, ICH Stability studies, Comparability studies, Downstream, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, Storage, Distribution
Address
Rheingaustrasse 190-196, 65203, Wiesbaden, Germany
Year
1998
United States
Other plants of this company

Cambrex Longmont location specializes in the early development of small molecule pharmaceutical products in a fully integrated drug substance and drug product facility.

Our Cambrex Milan site develops and manufactures proprietary products (generic APIs) and provides contract manufacturing services for intermediates and custom APIs at commercial scale.

Our team in Tallin has strong expertise in custom organic syntheses and contract R&D for pharmaceutical and fine chemical industries.
Contact us
If you have any questions or suggestions, click here. We will be happy to assist you.





